These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 9140499)

  • 1. Action of pentamidine-bound nanoparticles against Leishmania on an in vivo model.
    Fusai T; Deniau M; Durand R; Bories C; Paul M; Rivollet D; Astier A; Houin R
    Parasite; 1994 Dec; 1(4):319-24. PubMed ID: 9140499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ultrastructural changes in parasites induced by nanoparticle-bound pentamidine in a Leishmania major/mouse model.
    Fusai T; Boulard Y; Durand R; Paul M; Bories C; Rivollet D; Astier A; Houin R; Deniau M
    Parasite; 1997 Jun; 4(2):133-9. PubMed ID: 9296058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo antileishmanial action of Ir-(COD)-pentamidine tetraphenylborate on Leishmania donovani and Leishmania major mouse models.
    Loiseau PM; Mbongo N; Bories C; Boulard Y; Craciunescu DG
    Parasite; 2000 Jun; 7(2):103-8. PubMed ID: 10887656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activity of pentamidine-loaded poly (D,L-lactide) nanoparticles against Leishmania infantum in a murine model.
    Durand R; Paul M; Rivollet D; Fessi H; Houin R; Astier A; Deniau M
    Parasite; 1997 Dec; 4(4):331-6. PubMed ID: 9587601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activity of pentamidine-loaded methacrylate nanoparticles against Leishmania infantum in a mouse model.
    Durand R; Paul M; Rivollet D; Houin R; Astier A; Deniau M
    Int J Parasitol; 1997 Nov; 27(11):1361-7. PubMed ID: 9421724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of combined therapy with thalidomide and glucantime on leishmaniasis induced by Leishmania major in BALB/c mice.
    Solgi G; Kariminia A; Abdi K; Darabi M; Ghareghozloo B
    Korean J Parasitol; 2006 Mar; 44(1):55-61. PubMed ID: 16514283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro and in vivo resistance of Leishmania infantum to meglumine antimoniate: a study of 37 strains collected from patients with visceral leishmaniasis.
    Faraut-Gambarelli F; Piarroux R; Deniau M; Giusiano B; Marty P; Michel G; Faugère B; Dumon H
    Antimicrob Agents Chemother; 1997 Apr; 41(4):827-30. PubMed ID: 9087498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of meglumine antimoniate and pentamidine for peruvian cutaneous leishmaniasis.
    Andersen EM; Cruz-Saldarriaga M; Llanos-Cuentas A; Luz-Cjuno M; Echevarria J; Miranda-Verastegui C; Colina O; Berman JD
    Am J Trop Med Hyg; 2005 Feb; 72(2):133-7. PubMed ID: 15741547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of kala azar.
    Ozsoylu S
    Lancet; 1996 Jun; 347(9016):1701. PubMed ID: 8642997
    [No Abstract]   [Full Text] [Related]  

  • 10. Combination therapy with liposomal amphotericin b (ambisome), n-methylglucamine antimoniate (glucantime), and pentamidine isethionate in a refractory visceral leishmaniasis case.
    Gomes MAF; Medeiros LLC; Lobo FPD; Wanderley NRS; Matos APR; Jácome TDN; Monteiro MGL; Luz KG
    Rev Soc Bras Med Trop; 2018; 51(3):393-396. PubMed ID: 29972577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergistic effect of Ir-(COT)-pentamidine alizarin red and pentamidine, amphotericin B, and paromomycin on Leishmania donovani.
    Mbongo N; Loiseau PM; Craciunescu DG; Robert-Gero M
    Acta Trop; 1998 Jun; 70(2):239-45. PubMed ID: 9698271
    [No Abstract]   [Full Text] [Related]  

  • 12. Development of Leishmania (Viannia) panamensis lesions and relationship of numbers of amastigotes to lesion area on antimony-treated and untreated hamsters.
    Hanson WL; Chapman WL; Waits VB; Lovelace JK
    J Parasitol; 1991 Oct; 77(5):780-3. PubMed ID: 1919929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Resistance of Leishmania infantum to Glucantime: risk factors and therapeutic management].
    Piarroux R; Garnier JM; Gambarelli F; Dumon H; Kaplanski S; Unal D
    Arch Pediatr; 1996 Apr; 3(4):352-6. PubMed ID: 8762958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [In vitro study of leishmanicidal agents with drug carriers].
    Deniau M; Durand R; Bories C; Paul M; Astier A; Couvreur P; Houin R
    Ann Parasitol Hum Comp; 1993; 68(1):34-7. PubMed ID: 8494298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Responses of Leishmania (Viannia) braziliensis cutaneous infection to N-methylglucamine antimoniate in the rhesus monkey (Macaca mulatta) model.
    Teva A; Porrozzi R; Oliveira-Neto MP; Grimaldi GJ
    J Parasitol; 2005 Aug; 91(4):976-8. PubMed ID: 17089782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Uptake and antileishmanial activity of meglumine antimoniate-containing liposomes in Leishmania (Leishmania) major-infected macrophages.
    Borborema SE; Schwendener RA; Osso JA; de Andrade HF; do Nascimento N
    Int J Antimicrob Agents; 2011 Oct; 38(4):341-7. PubMed ID: 21783345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physicochemical characteristics of pentamidine-loaded polymethacrylate nanoparticles: implication in the intracellular drug release in Leishmania major infected mice.
    Paul M; Durand R; Boulard Y; Fusaï T; Fernandez C; Rivollet D; Deniau M; Astier A
    J Drug Target; 1998; 5(6):481-90. PubMed ID: 9783679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A trial of immunotherapy against Leishmania amazonensis infection in vitro and in vivo with Z-100, a polysaccharide obtained from Mycobacterium tuberculosis, alone or combined with meglumine antimoniate.
    Barroso PA; Marco JD; Calvopina M; Kato H; Korenaga M; Hashiguchi Y
    J Antimicrob Chemother; 2007 Jun; 59(6):1123-9. PubMed ID: 17439977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sensitivity of Leishmania braziliensis promastigotes to meglumine antimoniate (glucantime) is higher than that of other Leishmania species and correlates with response to therapy in American tegumentary leishmaniasis.
    Azeredo-Coutinho RB; Mendonça SC; Callahan H; Portal AC; Max G
    J Parasitol; 2007 Jun; 93(3):688-93. PubMed ID: 17626365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Canine visceral leishmaniasis: comparison of in vitro leishmanicidal activity of marbofloxacin, meglumine antimoniate and sodium stibogluconate.
    Vouldoukis I; Rougier S; Dugas B; Pino P; Mazier D; Woehrlé F
    Vet Parasitol; 2006 Jan; 135(2):137-46. PubMed ID: 16242844
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.